- Home
- HGBL vs PLRX Comparison
HGBL vs PLRX Comparison
Compare HGBL & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGBL
- PLRX
- Stock Information
- Founded
- HGBL 1937
- PLRX 2015
- Country
- HGBL United States
- PLRX United States
- Employees
- HGBL N/A
- PLRX N/A
- Industry
- HGBL Business Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- HGBL Consumer Discretionary
- PLRX Health Care
- Exchange
- HGBL Nasdaq
- PLRX Nasdaq
- Market Cap
- HGBL 75.5M
- PLRX 84.7M
- IPO Year
- HGBL N/A
- PLRX 2020
- Fundamental
- Price
- HGBL $2.11
- PLRX $1.44
- Analyst Decision
- HGBL Strong Buy
- PLRX Hold
- Analyst Count
- HGBL 1
- PLRX 10
- Target Price
- HGBL $4.00
- PLRX $9.79
- AVG Volume (30 Days)
- HGBL 66.8K
- PLRX 987.6K
- Earning Date
- HGBL 05-08-2025
- PLRX 05-08-2025
- Dividend Yield
- HGBL N/A
- PLRX N/A
- EPS Growth
- HGBL N/A
- PLRX N/A
- EPS
- HGBL 0.12
- PLRX N/A
- Revenue
- HGBL $46,659,000.00
- PLRX N/A
- Revenue This Year
- HGBL $11.74
- PLRX N/A
- Revenue Next Year
- HGBL $8.09
- PLRX N/A
- P/E Ratio
- HGBL $18.19
- PLRX N/A
- Revenue Growth
- HGBL N/A
- PLRX N/A
- 52 Week Low
- HGBL $1.52
- PLRX $1.10
- 52 Week High
- HGBL $2.74
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- HGBL 49.88
- PLRX 50.02
- Support Level
- HGBL $2.01
- PLRX $1.22
- Resistance Level
- HGBL $2.18
- PLRX $1.41
- Average True Range (ATR)
- HGBL 0.09
- PLRX 0.10
- MACD
- HGBL -0.00
- PLRX 0.02
- Stochastic Oscillator
- HGBL 38.46
- PLRX 78.57
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.